These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 18575763

  • 1. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T, Porteous A, Nicolle A, Proctor SJ, Anderson JJ, Summerfield G.
    Int J Oncol; 2008 Jul; 33(1):169-74. PubMed ID: 18575763
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M.
    Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
    Domingo-Domènech E, Domingo-Clarós A, Gonzàlez-Barca E, Beneitez D, Alonso E, Romagosa V, De Sanjos S, Petit J, Grañena A, Fernández de Sevilla A.
    Haematologica; 2002 Oct 15; 87(10):1021-7. PubMed ID: 12368155
    [Abstract] [Full Text] [Related]

  • 5. The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.
    Gentile M, Mauro FR, Calabrese E, De Propris MS, Giammartini E, Mancini F, Milani ML, Guarini A, Foà R.
    Br J Haematol; 2005 Aug 15; 130(4):549-57. PubMed ID: 16098069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data.
    Hock BD, McKenzie JL, McArthur L, Tansley S, Taylor KG, Fernyhough LJ.
    Intern Med J; 2010 Dec 15; 40(12):842-9. PubMed ID: 20002855
    [Abstract] [Full Text] [Related]

  • 9. Immunophenotypic characterization of the leukemic B-cells from Iranian patients with chronic lymphocytic leukemia: association between CD38 expression and disease progression.
    Hojjat Farsangi M, Jeddi-Tehrani M, Razavi SM, Sharifian RA, Shamsian Khoramabadi A, Rabbani H, Shokri F.
    Iran J Immunol; 2008 Mar 15; 5(1):25-35. PubMed ID: 18319522
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L.
    Am J Hematol; 2007 Sep 15; 82(9):787-91. PubMed ID: 17534928
    [Abstract] [Full Text] [Related]

  • 11. Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.
    Hewamana S, Lin TT, Rowntree C, Karunanithi K, Pratt G, Hills R, Fegan C, Brennan P, Pepper C.
    J Clin Oncol; 2009 Feb 10; 27(5):763-9. PubMed ID: 19124804
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis.
    Xu W, Li JY, Wu YJ, Cao X, Fan L, Qiao C, Liu Q, Yao L, Miao KR.
    Leuk Res; 2009 Dec 10; 33(12):1619-22. PubMed ID: 19250675
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I, Planinc-Peraica A, Ostojić Kolonić S, Radić-Kristo D, Milas M, Vrhovac R, Sustercić D, Minigo H, Jaksić B.
    Acta Med Croatica; 2008 Oct 10; 62(4):351-64. PubMed ID: 19205412
    [Abstract] [Full Text] [Related]

  • 14. Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
    Poggi A, Prevosto C, Catellani S, Rocco I, Garuti A, Zocchi MR.
    Br J Haematol; 2010 Nov 10; 151(3):252-64. PubMed ID: 20813004
    [Abstract] [Full Text] [Related]

  • 15. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L, Viaggi S, Zunino A, Zupo S, Rossi E, Spriano M, Abbondandolo A, Ferrarini M.
    Haematologica; 2003 Jul 10; 88(7):769-77. PubMed ID: 12857555
    [Abstract] [Full Text] [Related]

  • 16. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan 10; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]

  • 17. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
    Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5295-304. PubMed ID: 17875758
    [Abstract] [Full Text] [Related]

  • 18. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination.
    Rutella S, Rumi C, Puggioni P, Barberi T, Di Mario A, Larocca LM, Leone G.
    Haematologica; 1999 May 15; 84(5):419-24. PubMed ID: 10329920
    [Abstract] [Full Text] [Related]

  • 19. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D, Wojtowicz M, Ciszak L, Kosmaczewska A, Frydecka I, Potoczek S, Urbaniak-Kujda D, Kapelko-Slowik K, Kuliczkowski K.
    Eur J Haematol; 2009 Apr 15; 82(4):260-6. PubMed ID: 19187271
    [Abstract] [Full Text] [Related]

  • 20. Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progression.
    Matthews C, Catherwood MA, Morris TC, Kettle PJ, Drake MB, Gilmore WS, Alexander HD.
    Eur J Haematol; 2006 Oct 15; 77(4):309-17. PubMed ID: 16856923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.